← FDA Drug Approvals (Drugs@FDA)

TERBUTALINE SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL INJECTABLE · Approved 2004-04-23

Drug application

FDA Application #

ANDA076770

Application type

Abbreviated New Drug Application (Generic)

Brand name

TERBUTALINE SULFATE

Generic name

Terbutaline Sulfate

Active ingredients

TERBUTALINE SULFATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

CHARTWELL INJECTABLE

First approval

2004-04-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown